Available evidence on the use of GLP-1 analogues in women with polycystic ovary syndrome (PCOS): A scoping review

Read full text Summarise with VIRAT
Authors: Karina Alves Medeiros, Sara Oliveira da Silva, Mateus Duarte Dumont de Matos
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

This scoping review protocol aims to systematically map and synthesize the available scientific evidence on the use of GLP-1 receptor analogues in women with polycystic ovary syndrome (PCOS), focusing on metabolic and reproductive outcomes. The review includes observational and experimental studies published in English over the past 10 years, involving women of reproductive age diagnosed with PCOS. A comprehensive search was conducted in PubMed/MEDLINE, Scopus, and the BIREME Virtual Health Library. Study selection, data extraction, and synthesis follow the Joanna Briggs Institute methodology and PRISMA-ScR guidelines, with results presented through descriptive and narrative analysis.

Fields of Study & Subjects

Ovarian function and disorders Diabetes Treatment and Management Diabetes Cardiovascular Risks and Lipoproteins

Publication details

Publication date
1 January 2026
Language
EN
Document type
Preprint